237 related articles for article (PubMed ID: 30378473)
1. The Evolving Clinical Role of Actinium-225 and Bismuth-213 for Targeted Alpha Therapy (TAT) - Production, Radiopharmaceutical Development and Clinical Applications.
Radchenko V; Schaffer P; Knapp FFR
Curr Radiopharm; 2018; 11(3):154-155. PubMed ID: 30378473
[No Abstract] [Full Text] [Related]
2. An Overview of Targeted Alpha Therapy with
Morgenstern A; Apostolidis C; Kratochwil C; Sathekge M; Krolicki L; Bruchertseifer F
Curr Radiopharm; 2018; 11(3):200-208. PubMed ID: 29732998
[TBL] [Abstract][Full Text] [Related]
3. Development of
Robertson AKH; Ramogida CF; Schaffer P; Radchenko V
Curr Radiopharm; 2018; 11(3):156-172. PubMed ID: 29658444
[TBL] [Abstract][Full Text] [Related]
4. NorthStar Perspectives for Actinium-225 Production at Commercial Scale.
Harvey JT
Curr Radiopharm; 2018; 11(3):180-191. PubMed ID: 29766832
[TBL] [Abstract][Full Text] [Related]
5. Clinical Studies with Bismuth-213 and Actinium-225 for Hematologic Malignancies.
Jurcic JG
Curr Radiopharm; 2018; 11(3):192-199. PubMed ID: 29793418
[TBL] [Abstract][Full Text] [Related]
6. Bismuth-213 and actinium-225 -- generator performance and evolving therapeutic applications of two generator-derived alpha-emitting radioisotopes.
Morgenstern A; Bruchertseifer F; Apostolidis C
Curr Radiopharm; 2012 Jul; 5(3):221-7. PubMed ID: 22642390
[TBL] [Abstract][Full Text] [Related]
7. Targeted alpha therapy with bismuth-213 and actinium-225: Meeting future demand.
Bruchertseifer F; Kellerbauer A; Malmbeck R; Morgenstern A
J Labelled Comp Radiopharm; 2019 Sep; 62(11):794-802. PubMed ID: 31369165
[TBL] [Abstract][Full Text] [Related]
8. Progress in Targeted Alpha-Particle Therapy. What We Learned about Recoils Release from In Vivo Generators.
Kozempel J; Mokhodoeva O; Vlk M
Molecules; 2018 Mar; 23(3):. PubMed ID: 29510568
[TBL] [Abstract][Full Text] [Related]
9. The Production of Ac-225.
Engle JW
Curr Radiopharm; 2018; 11(3):173-179. PubMed ID: 29669509
[TBL] [Abstract][Full Text] [Related]
10.
Jiang Z; Revskaya E; Fisher DR; Dadachova E
Curr Radiopharm; 2018; 11(3):215-222. PubMed ID: 29683101
[TBL] [Abstract][Full Text] [Related]
11. Development of
Ondrák L; Ondrák Fialová K; Sakmár M; Vlk M; Bruchertseifer F; Morgenstern A; Kozempel J
Nucl Med Biol; 2024; 132-133():108909. PubMed ID: 38599144
[TBL] [Abstract][Full Text] [Related]
12. Retention studies of recoiling daughter nuclides of 225Ac in polymer vesicles.
Wang G; de Kruijff RM; Rol A; Thijssen L; Mendes E; Morgenstern A; Bruchertseifer F; Stuart MC; Wolterbeek HT; Denkova AG
Appl Radiat Isot; 2014 Feb; 85():45-53. PubMed ID: 24374072
[TBL] [Abstract][Full Text] [Related]
13. Dosimetry and Radiobiology of Alpha-Particle Emitting Radionuclides.
Sgouros G; Hobbs R; Josefsson A
Curr Radiopharm; 2018; 11(3):209-214. PubMed ID: 29697036
[TBL] [Abstract][Full Text] [Related]
14. Preliminary evaluation of alpha-emitting radioembolization in animal models of hepatocellular carcinoma.
Du Y; Cortez A; Josefsson A; Zarisfi M; Krimins R; Liapi E; Nedrow JR
PLoS One; 2022; 17(1):e0261982. PubMed ID: 35061763
[TBL] [Abstract][Full Text] [Related]
15. Production of high-purity radium-223 from legacy actinium-beryllium neutron sources.
Soderquist CZ; McNamara BK; Fisher DR
Curr Radiopharm; 2012 Jul; 5(3):244-52. PubMed ID: 22697483
[TBL] [Abstract][Full Text] [Related]
16.
Pfannkuchen N; Bausbacher N; Pektor S; Miederer M; Rosch F
Curr Radiopharm; 2018; 11(3):223-230. PubMed ID: 29866026
[TBL] [Abstract][Full Text] [Related]
17. A comparative evaluation of Ac225 vs Bi213 as therapeutic radioisotopes for targeted alpha therapy for cancer.
Allen BJ
Australas Phys Eng Sci Med; 2017 Jun; 40(2):369-376. PubMed ID: 28342027
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of nitrogen-rich macrocyclic ligands for the chelation of therapeutic bismuth radioisotopes.
Wilson JJ; Ferrier M; Radchenko V; Maassen JR; Engle JW; Batista ER; Martin RL; Nortier FM; Fassbender ME; John KD; Birnbaum ER
Nucl Med Biol; 2015 May; 42(5):428-438. PubMed ID: 25684650
[TBL] [Abstract][Full Text] [Related]
19. An Appendix of Radionuclides Used in Targeted Alpha Therapy.
Ferrier MG; Radchenko V
J Med Imaging Radiat Sci; 2019 Dec; 50(4 Suppl 1):S58-S65. PubMed ID: 31427258
[No Abstract] [Full Text] [Related]
20. Actinium-225 in targeted alpha-particle therapeutic applications.
Scheinberg DA; McDevitt MR
Curr Radiopharm; 2011 Oct; 4(4):306-20. PubMed ID: 22202153
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
